On the other hand, a case–control study showed that adropin levels decreased in patients with NASH and were negatively related to serum levels of alanine transaminase, aspartate aminotransferase, and gamma glutamyl transpeptidase. Here, GGTLC1 is linked to metabolic dysfunction-associated steatohepatitis.